David A. Spellman, SVP, CFO and Treasurer at Akebia Therapeutics, Inc. (AKBA), sold 8,203 shares at $2.15 ($18K) on 2022-02-28, disclosed to the SEC on 2022-03-02.
Open-market sale of $18k AKBA by SVP, CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.15 | 7,400 | $16K | 90.1% |
| 2 | $2.17 | 803 | $2K | 9.9% |
| Total | $2.15 avg | 8,203 | $18K | 100% |
| Filing → |
| AKBA | SELL | 2023-03-01 | $6K | — | Filing → |
| AKBA | SELL | 2021-04-01 | $3K | — | Filing → |